Table 1 Characteristics of patients in cerebral infarction group and healthy volunteers in control group
Cerebral infarction n = 284 Disease | Control n = 299 Control | P value cerebral infarction versus control | |
|---|---|---|---|
Male (%) | 190 (66.90) | 206 (68.89) | < .0001 |
Age | 64.87 ± 9.68 | 47.47 ± 8.20 | < .0001 |
CHOL (mmol/L) | 4.81 ± 1.51 | 4.79 ± 0.59 | < .0001 |
TG (mmol/L) | 1.53 ± 0.72 | 1.27 ± 0.36 | < .0001 |
HDL (mmol/L) | 1.33 ± 0.28 | 1.47 ± 0.25 | < .0001 |
LD L(mmol/L) | 2.46 ± 0.68 | 2.40 ± 0.32 | 0.0003 |
sdLD L(mmol/L) | 0.69 ± 0.29 | 0.55 ± 0.22 | 0.01 |
GLU (mmol/L) | 5.79 ± 1.63 | 4.70 ± 0.39 | < .0001 |
UA (mmol/L) | 339.13 ± 81.70 | 329.97 ± 59.07 | 0.01 |
hs CRP (mg/L) | 7.54 ± 8.08 | 1.82 ± 0.93 | < .0001 |
HCY(μmol/L) | 18.14 ± 6.62 | 10.77 ± 2.67 | < .0001 |
HbA1C(mmol/mol) | 6.26 ± 1.18 | 5.31 ± 0.31 | < .0001 |
LP-pla2(ng/ml) | 606.20 ± 156.44 | 365.82 ± 145.04 | 0.001 |
sdLDLc/HDLc | 0.56 ± 0.26 | 0.37 ± 0.15 | < .0001 |
(sdLDLc*HCYc)/HDLc | 10.26 ± 5.90 | 4.65 ± 1.82 | < .0001 |
Platelet(109/L) | 189.40 ± 47.46 | 211.99 ± 43.00 | < .0001 |
Neutrophil(109/L) | 4.53 ± 1.62 | 3.27 ± 0.72 | < .0001 |
Lymphocyte(109/L) | 1.60 ± 0.44 | 1.94 ± 0.44 | < .0001 |
Monocyte(109/L) | 0.52 ± 0.14 | 0.41 ± 0.09 | < .0001 |